BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Anavex Life Sciences Corp. 

50 Harrison St.
Suite 315A
Hoboken  New Jersey  07030  U.S.A.
Phone: 416-489-0092 or 866-505-2895 Fax: n/a


SEARCH JOBS








 Company News
Anavex Life Sciences Corp. (AVXL.OB) Strengthens Alzheimer's Pipeline, Obtains Exclusive Worldwide Rights To Intellectual Property 3/31/2014 9:51:50 AM    More...
Anavex Life Sciences Corp. (AVXL.OB) Reports Predicted Clinical Effect Of Both ANAVEX 2-73 And ANAVEX PLUS In A Humanized Cortical Cognitive Model For Alzheimer's Disease 3/28/2014 8:39:01 AM    More...
Anavex Life Sciences Corp. (AVXL.OB) Successfully Closes $10 Million Financing To Initiate Phase 1b/2a Alzheimer's Clinical Trial 3/19/2014 7:11:45 AM    More...
Anavex Life Sciences Corp. (AVXL.OB) Announces $10 Million Private Placement Of Convertible Debentures 3/13/2014 8:49:28 AM    More...
Anavex Life Sciences Corp. (AVXL.OB) Encouraged By Scientific Data Confirming Sigma-1 Receptor Agonist Extends Survival in ALS (Lou Gehrig's Disease) 3/10/2014 9:50:19 AM    More...
Anavex Life Sciences Corp. (AVXL.OB): Research Report Reveals Cardioprotective Action Of Sigma-1 Receptor Agonists 3/4/2014 9:00:52 AM    More...
Research Report Confirms Opportunity For Anavex Life Sciences Corp. (AVXL.OB) Anti-Cancer And Neuropathic Pain Compounds 2/26/2014 9:07:51 AM    More...
Anavex Life Sciences Corp. (AVXL.OB) To Present At 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/3/2014 8:47:38 AM    More...
Anavex Life Sciences Corp. (AVXL.OB) Release: Sigma-1 Receptor Implicated In Cell Survival Of Rare Neurodegenerative Diseases - Expanding The Opportunity For Application Of ANAVEX PLUS In Rare Diseases 1/23/2014 9:38:51 AM    More...
Anavex Life Sciences Corp. (AVXL.OB) Agreement With The Roskamp Institute To Advance The Clinical Development Of ANAVEX PLUS 1/13/2014 9:26:39 AM    More...
12345678910

//-->